Clinical Trials on Narcotic-Related Disorders

Total 159330 results

Sharon Walsh
National Institute on Drug Abuse (NIDA); Merck Sharp & Dohme LLC

Completed

Aprepitant Effects on Oxycodone Response

Narcotic Abuse

United States
Member Companies of the Opioid PMR Consortium
Kaiser Permanente; World Health Information Science Consultants, LLC

Completed

Study to Validate Coded Medical Terms Used to Identify Opioid-Related Overdose in Databases Used for PMR Study 1B

Opioid-Related Disorders | Drug Abuse | Opiate Addiction | Narcotic Abuse
ER/LA Opioid REMS Program Companies (RPC)

Unknown

Evaluation of Changes in Prescribing Behavior of ER/LA Opioid Prescribers

Drug Abuse | Opiate Addiction | Opioid Related Disorders | Narcotic Abuse
Member Companies of the Opioid PMR Consortium
Evidera

Completed

A Qualitative Study to Assess the Content Validity of the Prescription Opioid Misuse and Abuse Questionnaire (POMAQ)

Opioid-Related Disorders | Drug Abuse | Opiate Addiction | Narcotic Abuse

United States
Member Companies of the Opioid PMR Consortium
Evidera

Completed

A Quantitative Study to Assess the Construct Validity of the Prescription Opioid Misuse and Abuse Questionnaire (POMAQ)

Opioid-Related Disorders | Drug Abuse | Opiate Addiction | Narcotic Abuse
ER/LA Opioid REMS Program Companies (RPC)

Unknown

Monitoring Patterns of Prescribing to Identify Changes in Access to ER/LA Opioid Analgesics

Drug Abuse | Opiate Addiction | Opioid Related Disorders | Narcotic Abuse
ER/LA Opioid REMS Program Companies (RPC)

Unknown

ER/LA Opioid Analgesics - Surveillance Monitoring of State Medical Examiner Databases

Drug Abuse | Opioid-related Disorders | Narcotic Abuse | Opioid Addiction
Member Companies of the Opioid PMR Consortium
HealthCore, Inc.

Completed

A Survey to Eval the Relation Between Doctor/Pharmacy Shopping and Outcomes Suggestive of Misuse, Abuse and/or Diversion

Opioid-Related Disorders | Drug Abuse | Opiate Addiction | Narcotic Abuse
Vanderbilt University Medical Center

Terminated

Auricular Acupuncture to Facilitate Outpatient Opioid Weaning

Narcotic Addiction

United States
St. Louis University

Completed

A Prospective Assessment of Opioid Utilization Post-operatively in Sports Orthopaedic Surgeries (Opioids)

Postoperative Pain | Orthopedic Disorder | Opioid Use | Narcotic Use | Narcotic Abuse | Analgesic Drug Dependence | Opioids; Harmful Use | Opioid Abuse, Uncomplicated

United States
ER/LA Opioid REMS Program Companies (RPC)

Unknown

Evaluation of Drug Utilization Patterns for Extended Release/Long Acting Opioids and Comparator Products

Drug Abuse | Opiate Addiction | Opioid Related Disorders | Narcotic Abuse
ER/LA Opioid REMS Program Companies (RPC)

Unknown

Surveillance Monitoring of Opioid Abuse in Poison and Drug Treatment Centers

Drug Abuse | Opioid-related Disorders | Narcotic Abuse | Opioid Addiction
Indivior Inc.

Completed

Transfer of Subjects From Subutex/Suboxone to RBP-6300

Opioid Related Disorder

Austria, Czech Republic, Germany, Sweden
Indivior Inc.

Completed

Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects

Opioid Related Disorder

United States
Parnassia Addiction Research Centre
Radboud University Medical Center; Columbia University; Academisch Medisch Centrum... and other collaborators

Not yet recruiting

Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder

Cocaine Use Disorder
New York State Psychiatric Institute
University of New Mexico

Recruiting

Culturally Centering Medications for Opioid Use Disorder With American Indian and Alaska Native Communities (CTN-0096)

Opioid-use Disorder

United States
Prisma Health-Upstate
Clemson University

Recruiting

CBT4CBT-Buprenorphine + Recovery Coach for Office-based Buprenorphine

Opioid-use Disorder

United States
University of California, Irvine

Recruiting

Adapting the HOPE Online Support Intervention to Increase Uptake of Medications for Opioid Use Disorder (HOPE MOUD)

Opioid-use Disorder

United States
InSightec

Recruiting

Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD)

Opioid-use Disorder

United States
University of California, Los Angeles

Recruiting

Cannabidiol Effects on Craving and Relapse Prevention in Opioid Use Disorder

Opioid-use Disorder

United States
Massachusetts General Hospital

Terminated

Mindfulness Oriented Recovery Enhancement in Hospitalized People With Opioid Use Disorder

Opioid-use Disorder

United States
Johns Hopkins University
Centers for Disease Control and Prevention

Completed

Buprenorphine Treatment Engagement and Overdose Prevention

Opioid-use Disorder

United States
Dartmouth-Hitchcock Medical Center
National Center for Complementary and Integrative Health (NCCIH); Trustees...

Completed

Mindful Moms in Recovery (MMORE)

Opioid-use Disorder

United States
Johns Hopkins University
Patient-Centered Outcomes Research Institute

Active, not recruiting

Contingency Management to Enhance Office-Based Buprenorphine Treatment

Opioid-use Disorder

United States
Karen Derefinko, PhD
National Center for Complementary and Integrative Health (NCCIH); University... and other collaborators

Enrolling by invitation

SMART Trial for Buprenorphine-Naloxone Medication Assisted Treatment Adherence

Opioid-use Disorder

United States
Milton S. Hershey Medical Center
Columbia University; National Institutes of Health (NIH); Research Foundation... and other collaborators

Active, not recruiting

reSET-O RCT (Randomized Controlled Trial)

Opioid-use Disorder

United States
BioCorRx Inc
National Institute on Drug Abuse (NIDA); The HEAL Initiative (https://heal.nih...

Completed

Pharmacokinetic and Safety Study of Naltrexone Release From Subcutaneous BICX104 Pellets Compared to Vivitrol Injections

Opioid-use Disorder

United States
Orexo AB

Completed

OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder

Opioid-use Disorder

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Rural MOUD Telemedicine in Primary Care Phase 1 (Feasibility)

Opioid-use Disorder

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA); Baltimore City Health Department

Enrolling by invitation

Opioid Use Disorder Treatment Linkage at Sexual Health Clinics Using Buprenorphine (OUTLAST-B)

Opioid-use Disorder

United States
Lars Tanum
Oslo University Hospital; Haukeland University Hospital; The Hospital of Vestfold and other collaborators

Completed

Long Acting Naltrexone for Opioid Addiction: Focus on Sustained Abstinence and Recovery (NaltRec)

Opioid-use Disorder

Norway
Boston Medical Center
Substance Abuse and Mental Health Services Administration (SAMHSA)

Terminated

Response to Relapse in Office-Based Opioid Treatment Trial (RR-OBOT)

Opioid-use Disorder

United States
Alar Pharmaceuticals Inc.

Completed

Single Ascending Dose Study of ALA-1000

Opioid-use Disorder

United States
New York State Psychiatric Institute
USWM, LLC (dba US WorldMeds)

Completed

Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment

Opioid-use Disorder

United States
University of Maryland, Baltimore

Withdrawn

Safety and Preliminary Efficacy of ANS-6637 to Reduce Drug Craving and Harm in People With Opioid Use Disorder (SEARCH)

Opioid-use Disorder
University of Wisconsin, Madison
National Institute on Drug Abuse (NIDA)

Completed

Intervention to Expand Opioid Use Disorder Treatment Pharmacotherapy Prescribers

Opioid-use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of Intranasal Naltrexone and Naloxone

Opioid-use Disorder
Stony Brook University

Withdrawn

Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology

Opioid-use Disorder
University of Vermont

Unknown

Interim Buprenorphine Treatment to Bridge Waitlist Delays: Stage II Evaluation

Opioid-use Disorder

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl Use (ROLDI)

Opioid Use Disorder
Friends Research Institute, Inc.

Not yet recruiting

Buprenorphine for Individuals in Jail

Opioid Use Disorder

United States
University of Colorado, Denver
National Institute on Drug Abuse (NIDA)

Recruiting

A Multi-site Intervention to Expand Hospital Based OUD Treatment Provision

Opioid Use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Assessing Optimal XRB Initiation Points in Jail

Opioid Use Disorder

United States
University Hospital, Strasbourg, France

Recruiting

Biopsychosocial Markers of Addiction in Opioid Users: an Integrated Approach (BEBOP)

Opioid Use Disorder

France
Philadelphia College of Osteopathic Medicine
Prevention Point Philadelphia

Recruiting

Cognitive-Behavioral Therapy for Opioid Use Disorder: A Manualized Pilot Study

Opioid Use Disorder

United States
Friends Research Institute, Inc.
MATClinics

Recruiting

Low-dose Versus a High-dose Sublingual Buprenorphine Induction

Opioid Use Disorder

United States
Pouya Azar

Not yet recruiting

Symptom-inhibited Fentanyl Induction (SIFI)

Opioid Use Disorder
University of Kentucky
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Cannabis and Opioid Use Disorder

Opioid Use Disorder
Gazi University

Recruiting

Investigation of the Relationship Between Different Assesments in Individuals in Opioid Maintenance Treatment Process

Opioid Use Disorder

Turkey
University of Pennsylvania

Recruiting

Open Label Comparison of Injectable Buprenorphine ( Brixadi®) and Naltrexone (Vivitrol®) for Opioid Use Disorder

Opioid Use Disorder

United States

Clinical Trials on Narcotic-Related Disorders

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations